Short communication: ischemia/reperfusion tolerance is time-of-day-dependent: mediation by the cardiomyocyte circadian clock.
Short communication: ischemia/reperfusion tolerance is time-of-day-dependent: mediation by the cardiomyocyte circadian clock.
复制标题
DOI:
10.1161/circresaha.109.209346
复制
发表时间:
2010-02-19
影响因子:
20.1
通讯作者:
Young ME
中科院分区:
文献类型:
--
作者:
Durgan DJ;Pulinilkunnil T;Villegas-Montoya C;Garvey ME;Frangogiannis NG;Michael LH;Chow CW;Dyck JR;Young ME
Cardiovascular physiology and pathophysiology vary dramatically over the course of the day. For example, myocardial infarction (MI) onset occurs with greater incidence during the early morning hours in humans. However, whether MI tolerance exhibits a time-of-day-dependence is unknown. To investigate whether time-of-day of an ischemic insult influences clinically-relevant outcomes in mice. Wild-type (WT) mice were subjected to ischemia/reperfusion (I/R; 45 minutes ischemia followed by one day or one month reperfusion) at distinct times of the day, using the closed-chest left anterior descending coronary artery occlusion model. Following one day of reperfusion, hearts subjected to ischemia at the sleep-to-wake transition (ZT12) resulted in 3.5-fold increases in infarct size compared to hearts subjected to ischemia at the wake-to-sleep transition (ZT0). Following one month of reperfusion, prior ischemic event at ZT12 versus ZT0 resulted in significantly greater infarct volume, fibrosis, and adverse remodeling, as well as greater depression of contractile function. Genetic ablation of the cardiomyocyte circadian clock (termed CCM mice) attenuated/abolished time-of-day variations in I/R outcomes observed in WT hearts. Investigation of Akt and GSK-3β in WT and CCM hearts identified these kinases as potential mechanistic ties between the cardiomyocyte circadian clock and I/R tolerance. We expose a profound time-of-day-dependence for I/R tolerance, which is mediated by the cardiomyocyte circadian clock. Further understanding of I/R tolerance rhythms will potentially provide novel insight regarding the etiology and treatment of ischemia-induced cardiac dysfunction.